Neoadjuvant Therapy Improves Survival in Metastatic Colon Ca

Among patients with metastatic colon cancer with liver or lung lesions who received neoadjuvant therapy, survival was longer in comparison with patients who received adjuvant therapy, but only in nonacademic settings.

Related Keywords

Ohio , United States , Smitha Krishnamurthi , Zhonglin Hao , Pfizer , National Cancer Database , Bayer Inc , Cancer Center , Markey Cancer Center , National Comprehensive Cancer Network , University Of Kentucky , Medscape Medical , Cleveland Clinic , Published October , Colorectal Cancer , Neoadjuvant , Hepatocellular Carcinoma , Liver Cancer , Dcc , Hepatocellular Cancer , Ancer Liver , Ancer Hepatocellular , Colon Cancer , Alignant Colon Neoplasm , Cancer , Alignant Neoplasia , Arcinoma , Metastasis , Biologic Therapy , Chemotherapy , Lung Resection , Pulmonary Resection , Presection , Liver , Lung , Adjuvant Therapy , Surgery , Tumor , Boards , Smle , Antigens , Clinical Guidelines , Guidelines ,